NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/13/2025
Back to search
Official data from USPTO
CENKARE PHARMACY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
CENKARE PHARMACY
ST13
US500000086240391Class
35
Filing
86240391
Registration
4782917
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
12/02/2025
Classification
Registered
Trademark type
Word
Nice classes
35
Filing date
04/02/2014
Registration date
07/28/2015
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/13/2025
Last transaction
12/02/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/24/2014
First use in commerce
06/24/2014
Drawing code
4
Owner type
03
Owner location
St. Louis, MO
Examiner
LUDEMAN,JESSICA ANN
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
C. C. (pessoa física)
Representatives
Meredith P Gammill CENTENE CORPORATION
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Retail and online retail pharmacy services for dispensing pharmaceuticals to third parties
Publications
History of USPTO decisions and trademark events.
35 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/13/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/13/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/13/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
07/28/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/28/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/01/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/01/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/01/2020
E815
TEAS SECTION 8 & 15 RECEIVED
08/07/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/28/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
07/28/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/20/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/19/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/27/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/20/2015
IUAF
USE AMENDMENT FILED
04/22/2015
EISU
TEAS STATEMENT OF USE RECEIVED
04/22/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/28/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/02/2014
PUBO
PUBLISHED FOR OPPOSITION
09/02/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/13/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/28/2014
ALIE
ASSIGNED TO LIE
07/28/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/16/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
07/16/2014
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/16/2014
GNEA
EXAMINERS AMENDMENT E-MAILED
07/16/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/16/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/15/2014
GNRT
NON-FINAL ACTION E-MAILED
07/15/2014
CNRT
NON-FINAL ACTION WRITTEN
07/15/2014
DOCK
ASSIGNED TO EXAMINER
07/08/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/15/2014
NWAP
NEW APPLICATION ENTERED
04/05/2014
Continuous trademark protection
Get notified about every new filing that threatens CENKARE PHARMACY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.